深圳市海普瑞药业集团股份有限公司
Employees: 501-1000
Founded date: 1998
Investors 1
| Date | Name | Website |
| - | EGI Capita... | egicapital... |
Mentions in press and media 2
| Date | Title | Description |
| 28.03.2023 | OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab | SHENZHEN, China, March 28, 2023 /PRNewswire/ -- OncoVent Co., Ltd. ("OncoVent"), a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agre... |
| 20.06.2016 | Shenzhen Hepalink invests $60m in TPG Biotechnology’s latest fund | Premium Shenzhen Hepalink Pharmaceutical, the Shenzhen-listed Heparin producer, has injected $60 million into TPG Biotechnology Partners V with purposes to improve the fund’s efficiency and explore new business opportunities, according to t... |